PLA2R1 and nephrotic syndrome: According to KDIGO guidelines, individuals with nephrotic syndrome and positive anti-PLA2R antibodies may not need renal biopsy because the sensitivity and specificity of blood PLA2R antibody levels for the diagnosis of primary MN in the active phase are around 74% and 95%.